Denosumab alleviates intervertebral disc degeneration adjacent to lumbar fusion by inhibiting endplate osteochondral remodeling and vertebral osteoporosis in ovariectomized rats

Abstract

These results suggest that Dmab may be a novel therapeutic target for ASDD treatment.